Impact of azaproline on amide cis-trans isomerism: conformational analyses and NMR studies of model peptides including TRH analogues.

Department of Biochemistry, Washington University, St. Louis, Missouri 63110, USA.
Journal of the American Chemical Society (Impact Factor: 10.68). 03/2003; 125(5):1221-35. DOI: 10.1021/ja020994o
Source: PubMed

ABSTRACT The beta-turn is a well-studied motif in both proteins and peptides. Four residues, making almost a complete 180 degree-turn in the direction of the peptide chain, define the beta-turn. Several types of the beta-turn are defined according to Phi and Psi torsional angles of the backbone for residues i + 1 and i + 2. One special type of beta-turn, the type VI-turn, usually contains a proline with a cis-amide bond at residue i + 2. In an aza-amino acid, the alpha-carbon of the amino acid is changed to nitrogen. Peptides containing azaproline (azPro) have been shown to prefer the type VI beta-turn both in crystals and in organic solvents by NMR studies. MC/MD simulations using the GB/SA solvation model for water explored the conformational preferences of azPro-containing peptides in aqueous systems. An increase in the conformational preference for the cis-amide conformer of azPro was clearly seen, but the increased stability was relatively minor with respect to the trans-conformer as compared to previous suggestions. To test the validity of the calculations in view of the experimental data from crystal structures and NMR in organic solvents, [azPro(3)]-TRH and [Phe(2), azPro(3)]-TRH were synthesized, and their conformational preferences were determined by NMR in polar solvents as well as the impact of the azPro substitution on their biological activities.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Two model tetrapeptides containing bicyclic analogues of either D- or L-proline were synthesised and their conformational properties were studied by NMR in different solvent systems and by molecular modelling techniques. Compound 1, with the bicyclic D-proline mimetic in the i+1 position, generated a unique trans isomer, and the peptide showed a well organised structure, in accordance with the tendency of D-proline to act as a good turn inducer with respect to its enantiomer. Peptide 2 displayed structures equilibrating from type I,II to type VI β-turns, thus confirming the hypothesised relationship between the chirality of BGS/Bgs and proline enantiomers on nucleating compact turns. Moreover, such behaviour suggested a tool for peptidomimetic design of reverse turn peptides containing BGS/Bgs bicyclic proline mimetics, as the choice of chirality might influence the generation either of compact γ- and β-turns or of flexible equilibrating reverse turn structures. The effect of solvent on conformational behaviour was also studied. (© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2004)
    Annalen der Chemie und Pharmacie 11/2004; 2004(22):4621 - 4627. · 3.10 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A specific ligand targeting the immunodominant region of hepatitis B virus (HBV) is desired in neutralizing the infectivity of the virus. In a previous study, a disulfide constrained cyclic peptide cyclo S(1) ,S(9) Cys-Glu-Thr-Gly-Ala-Lys-Pro-His-Cys (S(1) , S(9) -cyclo-CETGAKPHC) was isolated from a phage displayed cyclic peptide library using an affinity selection method against HBV surface antigen (HBsAg). The cyclic peptide binds tightly to HBsAg with a relative dissociation constant (K(D) (rel) ) of 2.9 nM. The binding site of the peptide was located at the immunodominant region on HBsAg. Consequently, this study was aimed to elucidate the structure of the cyclic peptide and its interaction with HBsAg in silico. The solution structure of this cyclic peptide was solved using (1) H, (13) C and (15) N NMR spectroscopy and molecular dynamics (MD) simulations with NMR-derived distance and torsion angle restraints. The cyclic peptide adopted two distinct conformations due to the isomerization of the Pro residue with one structured region in the ETGA sequence. Docking studies of the peptide ensemble with a model structure of HBsAg revealed that the cyclic peptide can potentially be developed as a therapeutic drug that inhibits the virus-host interactions. © 2013 John Wiley & Sons A/S.
    Chemical Biology &amp Drug Design 02/2013; · 2.47 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The first total synthesis of Rolloamide B, a cyclic proline-enriched heptapeptide, is reported. This work features solution phase benzotriazole-mediated peptide synthesis ligating native amino acids.
    Chemical Communications 03/2013; 49(26):2631-3. · 6.38 Impact Factor